Summary
Invasive potentials of malignant cancer cells are regulated by cell motility factors. To examine the regulation of motility and invasiveness in oral squamous carcinoma, we investigated autocrine- and/or paracrine-acting cell motility factors, using a newly established human cell line (IF cells) from oral squamous cell carcinoma, which has highly invasive and metastatic characteristics. Conditioned medium derived from IF cells stimulated cell scattering and migration of GB-d1 gallbladder carcinoma cells, indicating that IF cells secreted cell motility factors. Using antibodies, IF-derived cell motility factors proved to be transforming growth factor (TGF)-α and TGF-β1. Antibodies against TGF-α and TGF-β1 inhibited autonomous migration of the IF cells. On the other hand, in vitro invasion of IF cells was strongly enhanced by hepatocyte growth factor (HGF) but only slightly by TGF-α and TGF-β1. The conditioned medium from fibroblasts enhanced in vitro invasion of IF cells, an event abrogated by anti-HGF antibody, but not by antibodies against TGF-α and TGF-β1. Importantly, IF cells secreted a factor inducing HGF production in fibroblasts and the factor was identified as interleukin-1, which means that a mutual interaction exists between tumour cells and fibroblasts, as mediated by the HGF/HGF-inducer loop. These results indicate that IF cells utilize TGF-α and TGF-β1 as autocrine-acting motility factors and HGF as a paracrine-acting motility factor, and that invasiveness of IF cells is particularly stimulated by HGF derived from stromal fibroblasts. Utilization of multiple cell motility/invasion factors that act in distinct pathways may confer highly invasive and metastatic potentials in IF oral squamous carcinoma cells.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bennett, J. H., Furness, J., Atkin, P. & Speight, P. M. (1997). Scatter factor (SF) regulation of matrix metalloproteinase production by oral carcinoma cells. J Dental Res 76: 2140
Birchmeier, C. & Gherardi, E. (1998). Developmental role of HGF/SF and its receptor, the Met tyrosine kinase. Trends Cell Biol 8: 404–410.
Bussolino, F., DiRenzo, M. F., Ziche, M., Bochietto, E., Olivero, M., Naldini, L., Goudino, G., Tamagnone, L., Coffer, A. & Comoglio, P. M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629–641.
Camps, J. L., Chang, S., Hsu, T. C., Freeman, M. R., Hong, S., Zhau, H. E., von Eschenbach, A. C. & Chung, L. W. K. (1990). Fibroblast-mediated acceleration of human epithelial tumour growth in vivo. Proc Natl Acad Sci USA 87: 75–79.
Chicoine, M. R. & Silbergeld, D. L. (1997). Mitogens as motogens. J Neurooncol 35: 249–257.
Date, K., Matsumoto, K., Shimura, H., Tanaka, M. & Nakamura, T. (1997). HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett 420: 1–6.
Date, K., Matsumoto, K., Shimura, H., Tanaka, M. & Nakamura, T. (1998). Inhibition of tumour growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 17: 3045–3054.
Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. V., Williams, R. D., Bringman, T. S. & Berger, W. H. (1987). Synthesis of messenger RNAs for transforming growth factor-α and β and the epidermal growth factor receptor by human tumours. Cancer Res 47: 707–712.
Dunsmore, S. E., Rubin, J. S., Kovacs, S. O., Chedid, M., Parks, W. C. & Welgus, H. G. (1996). Mechanisms of hepatocyte growth factor-stimulation of keratinocyte metalloproteinase production. J Biol Chem 271: 24567–24582.
El Obeid, A., Bongcan-Rudloff, E., Sorby, M., Ostman, A., Nister, M. & Westermark, B. (1997). Cell scattering and invasion induced by autocrine transforming growth factor-α in human glioma cells in vitro. Cancer Res 57: 5598–5604.
Furlong, R. A., Takehara, T., Taylor, W. G., Nakamura, T. & Rubin, J. S. (1991). Comparison of biological and immunochemical properties indicate that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci 100: 173–177.
Gherardi, E., Gray, J., Stoker, M., Perryman, M. & Furlong, R. (1989). Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interaction and movement. Proc Natl Acad Sci USA 86: 5844–5848.
Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. I., Polverini, P. & Rosen, E. M. (1993). Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937–1941.
Hiscox, S. & Jiang, W. G. (1999). HGF/SF regulates the phosphorylation of β-catenin and cell–cell adhesion in cancer cells. Proc Am Assoc Cancer Res, in press
Inoue, T., Chung, Y. S., Yashiro, M., Nishimura, S., Hasuma, T., Otani, S. & Sowa, M. (1997). Transforming growth factor-β and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 88: 152–159.
Jeffers, M., Rong, S. & Vande Woude, G. F. (1996). Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115–1125.
Jiang, W. G., Hallett, M. B. & Puntis, M. C. (1993). Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 80: 1368–1373.
Jiang, W. G., Hiscox, S., Matsumoto, K. & Nakamura, T. (1999). Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29: 209–248.
Konishi, T., Takehara, T., Tsuji, T., Ohsato, K., Matsumoto, K. & Nakamura, T. (1991). Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor. Biochem Biophys Res Commun 180: 765–773.
Lamszus, K., Jin, L., Fuchs, A., Shi, E., Chowdhury, S., Yao, Y., Polverini, P. J., Laterra, J., Goldberg, I. D. & Rosen, E. M. (1997). Scatter factor stimulates tumour growth and angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest 76: 339–353.
Levine, M. D., Liotta, L. A. & Stracke, M. L. (1995). Stimulation and regulation of tumour cell motility in invasion and metastasis. In Epithelial–Mesenchymal Interactions in Cancer EXS 74: 157–179
Matsumoto, K. & Nakamura, T. (1997). Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239: 639–644.
Matsumoto, K., Horikoshi, M., Rikimaru, K. & Enomoto, S. (1989). A study of an in vitro model for invasion of oral squamous cell carcinoma. J Oral Pathol Med 18: 498–501.
Matsumoto, K., Matsumoto, K., Nakamura, T. & Kramer, R. H. (1994). Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269: 31807–31813.
Matsumoto, K., Date, K., Shimura, H. & Nakamura, T. (1996). Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res 87: 702–710.
Miyazawa, K., Tsubouchi, H., Naka, D., Takahashi, K., Okigaki, M., Gohda, E., Daikuhara, Y. & Kitamura, N. (1989). Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163: 967–973.
Mooradian, D. L., McCarthy, J. B., Kommanduri, K. V. & Furcht, L. T. (1992). Effect of transforming growth factor-β1 on human pulmonary adenocarcinoma cell adhesion, motility and invasion in vitro. J Natl Cancer Inst 84: 523–527.
Nakamura, T., Nawa, K. & Ichihara, A. (1984). Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450–1459.
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K. & Shimizu, S. (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443.
Nakamura, T., Matsumoto, K., Kiritoshi, A., Tano, Y. & Nakamura, T. (1997). Induction of hepatocyte growth factor in fibroblasts by tumour-derived factors affects invasive growth of tumour cells: in vitro analysis of tumour-stromal interactions. Cancer Res 57: 3305–3313.
Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R. & Michalopoulos, G. K. (1991). Hepatocyte growth factor and scatter factor are indistinguishable ligands for the Met receptor. EMBO 10: 2867–2878.
Okada, F., Yamaguchi, K., Ichihara, A. & Nakamura, T. (1989). Purification and structural analysis of a latent transforming growth factor-β from rat platelets. J Biochem 106: 304–310.
Pepper, M. S., Matsumoto, K., Nakamura, T., Orci, L. & Montesano, R. (1992). Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 267: 20493–20496.
Ridly, A. J., Comoglio, P. M. & Hall, A. (1995). Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac and Rho in MDCK cells. Mol Cell Biol 15: 1110–1122.
Russell, W. E., McGowan, J. A. & Bucher, N. L. R. (1984). Partial characterization of hepatocyte growth factor from rat platelets. J Cell Physiol 119: 183–192.
Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Oku, N., Miyazawa, K., Kitamura, N., Takeichi, M. & Ito, F. (1994). Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1: 295–305.
Silletti, S. & Raz, A. (1996). Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis. Curr Top Microbiol Immunol 213: 137–169.
Sporn, M. B. & Roberts, A. B. (1985). Autocrine growth factors and cancer. Nature 313: 745–747.
Sporn, M. B., Roberts, A. B., Wakefield, L. M. & de Crombrugghe, B. (1987). Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 105: 1039–1045.
Stoker, M. & Gherardi, E. (1991). Regulation of cell movement: the motogenic cytokines. Biochem Biophys Acta 1072: 81–102.
Stoker, M. & Perryman, M. (1985). An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77: 209–223.
Takaishi, K., Sasaki, T., Kato, M., Yamori, W., Kuroda, S., Nakamura, T., Takeichi, M. & Takai, Y. (1994). Involvement of rho p21 small GTP-binding protein and its regulatory protein in the HGF-induced cell motility. Oncogene 9: 273–279.
Ueda, M., Fujii, H., Yoshizawa, K., Abe, F. & Ueki, M. (1996). Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cell in vitro. Jpn J Cancer Res 87: 524–533.
Ueda, M., Ueki, M., Morimoto, A., Fujii, H., Yoshizawa, K. & Yanagisawa, T. (1997). Stimulatory effects of EGF and TGF-α on invasive activity and 5′-deoxy-5- fluorouridine sensitivity in uterine cervical carcinoma SKG-IIIb cells. Int J Cancer 72: 1027–1033.
Ullrich, A. & Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212.
van den Hooff, A. (1988). Stromal involvement in malignant growth. Adv Cancer Res 50: 159–196.
Watabe, M., Matsumoto, K., Nakamura, T. & Takeichi, M. (1993). Effect of hepatocyte growth factor on cadherin-mediated cell–cell adhesion. Cell Struc Function 18: 117–124.
Wehrle-Haller, B. & Weston, J. A. (1997). Receptor tyrosine kinase-dependent neural crest migration in response to differentially localized growth factors. Bioessays 19: 337–345.
Weidner, K. M., Behrens, J., Vanderkerckhove, J. & Birchmeier, W. (1990). Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097–2108.
Weidner, K. M., Arakaki, N., Hartmann, G., Vanderkerckhove, J., Weingort, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, T., Daikuhara, Y. & Birchmeier, W. (1991). Evidence for identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001–7005.
Welch, D. R., Fabba, A. & Nakajima, M. (1990). Transforming growth factor-β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87: 7678–7682.
Wernert, N. (1997). The multiple roles of tumour stroma. Virchows Arch 430: 433–443.
Wright, J. A. & Huang, A. (1996). Growth factors in mechanisms of malignancy: roles for TGF-β and FGF. Histol Histopathol 11: 521–536.
Wright, J. A., Turley, E. A. & Greenberg, A. H. (1993). Transforming growth factor-β and fibroblast growth factor as promoters of tumour progression to malignancy. Crit Rev Oncog 4: 473–492.
Zarnegar, R. & Michalopoulas, G. K. (1995). The many faces of hepatocyte growth factor: from haptopoiesis to hematopoiesis. J Cell Biol 129: 1177–1180.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hasina, R., Matsumoto, K., Matsumoto-Taniura, N. et al. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br J Cancer 80, 1708–1717 (1999). https://doi.org/10.1038/sj.bjc.6690587
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690587
Keywords
This article is cited by
-
Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review
Molecular Cancer (2019)
-
Norepinephrine induced epithelial–mesenchymal transition in HT-29 and A549 cells in vitro
Journal of Cancer Research and Clinical Oncology (2016)
-
Hepatic stellate cells: central modulators of hepatic carcinogenesis
BMC Gastroenterology (2015)
-
Involvement of intracellular free Ca2+ in enhanced release of herpes simplex virus by hydrogen peroxide
Virology Journal (2006)
-
Enhancement of antitumor activity of herpes simplex virus γ134.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide
Cancer Gene Therapy (2006)